Utama › Nefritis Lupus › Ohio
Kajian klinikal Nefritis Lupus di Ohio
7 kajian untuk Nefritis Lupus sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Cleveland Clinic Foundation, Cleveland
Mengambil pesertaFasa 2
Umur 18 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05268289The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 8 hingga 20 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05538208A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cincinnati Childrens Hospital, Cincinnati
Mengambil pesertaFasa 2
Umur 5 hingga 17 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT05039619Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
- GSK Investigational Site, Columbus
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06527872A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
Mengambil pesertaFasa 1
Umur 12 hingga 70 · Semua jantina · Dikemas kini 22 Mei 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The MetroHealth System, Cleveland
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 110 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT05934149Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Nephrology Clinical Trials Unit The Ohio State University Wexner Medical Center, Columbus
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 6 Nov 2025 · NCT07225387Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.